Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
Elocon 0.1% w/w Cream.
| Pharmaceutical Form |
|---|
|
Cream. |
Mometasone furoate 0.1% w/w.
For full list of excipients see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mometasone |
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
| List of Excipients |
|---|
|
Hexylene glycol |
5, 15, 30 and 100 gram size, epoxy lined aluminum tubes having a screw threaded neck finish sealed with an aluminum membrane. Each tube is supplied with a white high density polyethylene (HDPE) screw cap which has a piercing tip to puncture open the aluminum membrane on the neck.
Not all pack sizes may be marketed.
Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
PL 00025/0577
19 November 1991 / 15 April 2002
| Drug | Countries | |
|---|---|---|
| ELOCON | Austria, Australia, Cyprus, Germany, Estonia, Finland, Ireland, Lithuania, Netherlands, New Zealand, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
